These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 32499779)

  • 1. Role of CC Chemokines Subfamily in the Platinum Drugs Resistance Promotion in Cancer.
    Reyes ME; de La Fuente M; Hermoso M; Ili CG; Brebi P
    Front Immunol; 2020; 11():901. PubMed ID: 32499779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
    Erin N; Grahovac J; Brozovic A; Efferth T
    Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparanase: From basic research to therapeutic applications in cancer and inflammation.
    Vlodavsky I; Singh P; Boyango I; Gutter-Kapon L; Elkin M; Sanderson RD; Ilan N
    Drug Resist Updat; 2016 Nov; 29():54-75. PubMed ID: 27912844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secreted Soluble Factors from Tumor-Activated Mesenchymal Stromal Cells Confer Platinum Chemoresistance to Ovarian Cancer Cells.
    Koren Carmi Y; Khamaisi H; Adawi R; Noyman E; Gopas J; Mahajna J
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokines driven ovarian cancer progression, metastasis and chemoresistance: Potential pharmacological targets for cancer therapy.
    Bose S; Saha P; Chatterjee B; Srivastava AK
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):568-579. PubMed ID: 35378273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
    Dzobo K
    OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy.
    Morein D; Erlichman N; Ben-Baruch A
    Front Immunol; 2020; 11():952. PubMed ID: 32582148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A highly annotated database of genes associated with platinum resistance in cancer.
    Huang D; Savage SR; Calinawan AP; Lin C; Zhang B; Wang P; Starr TK; Birrer MJ; Paulovich AG
    Oncogene; 2021 Nov; 40(46):6395-6405. PubMed ID: 34645978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of REG4 expression on chemoresistance of ovarian cancer.
    Xiang LW; Xue H; Ha MW; Yu DY; Xiao LJ; Zheng HC
    J Obstet Gynaecol; 2022 Oct; 42(7):3149-3157. PubMed ID: 35929918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondria and cancer chemoresistance.
    Guerra F; Arbini AA; Moro L
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to platinum-based cancer drugs: a special focus on epigenetic mechanisms.
    Mora Y; Reyes ME; Zanella L; Mora B; Buchegger K; Ili C; Brebi P
    Pharmacogenomics; 2021 Aug; 22(12):777-790. PubMed ID: 34281355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms underlying acquired platinum resistance in high grade serous ovarian cancer - a mini review.
    Binju M; Padilla MA; Singomat T; Kaur P; Suryo Rahmanto Y; Cohen PA; Yu Y
    Biochim Biophys Acta Gen Subj; 2019 Feb; 1863(2):371-378. PubMed ID: 30423357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands.
    Korbecki J; Grochans S; Gutowska I; Barczak K; Baranowska-Bosiacka I
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour Cell Secretome in Chemoresistance and Tumour Recurrence.
    Madden EC; Gorman AM; Logue SE; Samali A
    Trends Cancer; 2020 Jun; 6(6):489-505. PubMed ID: 32460003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flavonoids Restore Platinum Drug Sensitivity to Ovarian Carcinoma Cells in a Phospho-ERK1/2-Dependent Fashion.
    Koren Carmi Y; Mahmoud H; Khamaisi H; Adawi R; Gopas J; Mahajna J
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32906729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of anticancer therapies with tumor-associated macrophages.
    Mantovani A; Allavena P
    J Exp Med; 2015 Apr; 212(4):435-45. PubMed ID: 25753580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach.
    Taylor S; Spugnini EP; Assaraf YG; Azzarito T; Rauch C; Fais S
    Drug Resist Updat; 2015 Nov; 23():69-78. PubMed ID: 26341193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Battling Chemoresistance in Cancer: Root Causes and Strategies to Uproot Them.
    Ramos A; Sadeghi S; Tabatabaeian H
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-associated mesothelial cells promote ovarian cancer chemoresistance through paracrine osteopontin signaling.
    Qian J; LeSavage BL; Hubka KM; Ma C; Natarajan S; Eggold JT; Xiao Y; Fuh KC; Krishnan V; Enejder A; Heilshorn SC; Dorigo O; Rankin EB
    J Clin Invest; 2021 Aug; 131(16):. PubMed ID: 34396988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of CC-Chemokines in the Regulation of Angiogenesis.
    Ridiandries A; Tan JT; Bursill CA
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.